References
- Hummel T, Whitcroft K, Andrews P, et al. Position paper on olfactory dysfunction. Rhinol Suppl. 2017;54(26):1–30.
- Débat H, Eloit C, Blon F, et al. Identification of human olfactory cleft mucus proteins using proteomic analysis. J Proteome Res. 2007;6(5):1985–1996.
- Smith TL, Schlosser RJ, Soler ZM, et al. Olfactory cleft mucus inflammatory proteins in CRS: a case-control study. Int Forum Allergy Rhinol. 2021;11(9):1321–1335.
- Yoo F, Soler ZM, Mulligan JK, et al. Olfactory cleft mucus proteins associated with olfactory dysfunction in a cohort without chronic rhinosinusitis. Int Forum Allergy Rhinol. 2019;9(10):1151–1158.
- Klimek L, Rasp G. Norm values for eosinophil cationic protein in nasal secretions: influence of specimen collection. Clin Exp Allergy. 1999;29(3):367–374.
- Zhang M, Yan B, Wang Y, et al. Charcot-Leyden crystal protein in nasal secretions of patients with nonallergic rhinitis with eosinophilia syndrome. Int Arch Allergy Immunol. 2020;181(11):888–896.
- Soler ZM, Yoo F, Schlosser RJ, et al. Correlation of mucus inflammatory proteins and olfaction in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2020;10(3):343–355.
- Thwaites RS, Jarvis HC, Singh N, et al. Absorption of nasal and bronchial fluids: precision sampling of the human respiratory mucosa and laboratory processing of samples. J Vis Exp. 2018;(131):e56413.
- Watelet J-B, Gevaert P, Holtappels G, et al. Collection of nasal secretions for immunological analysis. Eur Arch Otorhinolaryngol. 2004;261(5):242–246.
- Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhin. 2020;58(1):1–464.
- Wu D, Li Y, Bleier BS, et al. Superior turbinate eosinophilia predicts olfactory decline in patients with chronic rhinosinusitis. Ann Allergy Asthma Immunol. 2020;125(3):304–310.
- Klimek L, Wolf H, Mewes T, et al. The effect of short-term immunotherapy with molecular standardized grass and rye allergens on eosinophil cationic protein and tryptase in nasal secretions. J Allergy Clin Immunol. 1999;103(1):47–53.
- Zhao X, Grewal A, Briel M, et al. A systematic review of nonabsorbable, absorbable, and steroid-impregnated spacers following endoscopic sinus surgery. Int Forum Allergy Rhinol. 2013;3(11):896–904.
- You Y, Park WH, Ko BM, et al. Effects of PVA sponge containing chitooligosaccharide in the early stage of wound healing. J Mater Sci Mater Med. 2004;15(3):297–301.
- Persson EK, Verstraete K, Heyndrickx I, et al. Protein crystallization promotes type 2 immunity and is reversible by antibody treatment. Science. 2019;364(6442):eaaw4295.
- Lavin J, Min JY, Lidder AK, et al. Superior turbinate eosinophilia correlates with olfactory deficit in chronic rhinosinusitis patients. Laryngoscope. 2017;127(10):2210–2218.
- Stevens WW, Peters AT, Tan BK, et al. Associations between inflammatory endotypes and clinical presentations in chronic rhinosinusitis. J Allergy Clin Immunol Pract. 2019;7(8):2812–2820.
- Wu D, Yan B, Wang Y, et al. Predictive significance of Charcot-Leyden crystal protein in nasal secretions in recurrent chronic rhinosinusitis with nasal polyps. Int Arch Allergy Immunol. 2021;182(1):65–75.
- Riechelmann H, Deutschle T, Friemel E, et al. Biological markers in nasal secretions. Eur Respir J. 2003;21(4):600–605.
- Sambasivam M, White R, Cutting K. Exploring the role of polyurethane and polyvinyl alcohol foams in wound care. Wound healing biomaterials. Amsterdam, Netherlands: Elsevier; 2016. p. 251–260.